Though IHC analysis of clinical primary tumour and paired liver metastasis both showed high expression of CLDN2 without statistical difference between groups, patients with increased CLDN2 levels in primary tumour developed more with liver metastasis within 5 years. The gene discussed is CLDN2; the disease is neoplasm.